GILD vs UNIT · P/E 18, rev $29.44B vs P/E 2.7, rev $722.6M
Gilead Sciences Inc (GILD) versus Uniti Group Inc (UNIT) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Uniti Group Inc (UNIT) is a reit - specialty company listed on NASDAQ.
Latest reported GILD revenue for 2025-12-31 was $29.44B. Net income was $8.51B. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported UNIT revenue for 2025-09-30 was $722.6M. Net income was $1.61B. Revenue was up 147.3% from 2024-09-30 to 2025-09-30. UNIT currently screens at market cap $2.96B and trailing P/E 2.7.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. UNIT currently screens at market cap $2.96B and trailing P/E 2.7.
Not investment advice. Open the GILD and UNIT stock pages for the full models.
Not investment advice.